Detalhe da pesquisa
1.
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand.
Eur J Nucl Med Mol Imaging
; 50(9): 2872-2884, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060367
2.
Comparison of risk-calculator and MRI and consecutive pathways as upfront stratification for prostate biopsy.
World J Urol
; 39(7): 2453-2461, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090259
3.
Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial.
J Nucl Med
; 65(3): 423-429, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176721
4.
How Image-Guided Pathology Can Improve the Detection of Lymph Node Metastases in Prostate Cancer.
Clin Nucl Med
; 47(6): 559-561, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439175
5.
How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.
Eur Urol
; 82(6): 578-580, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167598
6.
Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients.
J Nucl Med
; 62(9): 1258-1263, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33517328
7.
Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology.
Prostate Cancer Prostatic Dis
; 24(2): 423-430, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32999466
8.
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study.
Clin Cancer Res
; 27(13): 3595-3601, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33883176
9.
Reply to Francesco Montorsi, Simone Scuderi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80.
Eur Urol
; 83(5): e133-e134, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781337